These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Effects of interleukin-1 and anti-inflammatory drugs on the degradation of human articular cartilage. Shinmei M; Kikuchi T; Masuda K; Shimomura Y Drugs; 1988; 35 Suppl 1():33-41. PubMed ID: 2834169 [TBL] [Abstract][Full Text] [Related]
9. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. Martel-Pelletier J; McCollum R; Fujimoto N; Obata K; Cloutier JM; Pelletier JP Lab Invest; 1994 Jun; 70(6):807-15. PubMed ID: 8015285 [TBL] [Abstract][Full Text] [Related]
10. Neutral metalloproteases and age related changes in human articular cartilage. Martel-Pelletier J; Pelletier JP Ann Rheum Dis; 1987 May; 46(5):363-9. PubMed ID: 3296969 [TBL] [Abstract][Full Text] [Related]
11. Studies on the release of proteolytic enzymes during synovium-induced cartilage breakdown in vitro and the actions of anti-inflammatory drugs. Crossley MJ; Hunneyball IM Biochem Pharmacol; 1984 Apr; 33(8):1263-71. PubMed ID: 6324820 [TBL] [Abstract][Full Text] [Related]
12. Degradative changes in human articular cartilage induced by chemotherapeutic agents. Martel-Pelletier J; Pelletier JP J Rheumatol; 1986 Feb; 13(1):164-74. PubMed ID: 3701730 [TBL] [Abstract][Full Text] [Related]
13. [The enzymatic mechanisms involved in the pathogenesis of rheumatoid arthritis and arthrosis. The role of metalloproteases and serine proteases in the breakdown of articular cartilage]. Lombardi A; Pignone A; Perfetto F; Tarquini R; Partsch G; Matucci-Cerinic M Recenti Prog Med; 1993 Sep; 84(9):634-41. PubMed ID: 8210629 [TBL] [Abstract][Full Text] [Related]
14. The role of alpha-1-protease inhibitor (A1PI) in the inhibition of protease activity in human knee osteoarthritis. Awbrey BJ; Kuong SJ; MacNeil KL; Wright M Agents Actions Suppl; 1993; 39():167-71. PubMed ID: 8456628 [TBL] [Abstract][Full Text] [Related]
15. Collagenase-3 (matrix metalloprotease 13) is preferentially localized in the deep layer of human arthritic cartilage in situ: in vitro mimicking effect by transforming growth factor beta. Moldovan F; Pelletier JP; Hambor J; Cloutier JM; Martel-Pelletier J Arthritis Rheum; 1997 Sep; 40(9):1653-61. PubMed ID: 9324020 [TBL] [Abstract][Full Text] [Related]
16. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints. Lark MW; Bayne EK; Flanagan J; Harper CF; Hoerrner LA; Hutchinson NI; Singer II; Donatelli SA; Weidner JR; Williams HR; Mumford RA; Lohmander LS J Clin Invest; 1997 Jul; 100(1):93-106. PubMed ID: 9202061 [TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of leflunomide therapy on the activity of matrixmetalloproteinase-9 and the release of cartilage oligomeric matrix protein in patients with rheumatoid arthritis. Kullich WC; Mur E; Aglas F; Niksic F; Czerwenka C Clin Exp Rheumatol; 2006; 24(2):155-60. PubMed ID: 16762150 [TBL] [Abstract][Full Text] [Related]
18. Two latent metalloproteases of human articular cartilage that digest proteoglycan. Woessner JF; Selzer MG J Biol Chem; 1984 Mar; 259(6):3633-8. PubMed ID: 6368548 [TBL] [Abstract][Full Text] [Related]
19. Cartilage degradation by neutral metalloproteases in experimental collagen-like syndrome. Drozdz M; Skop B; Jendryczko A Exp Pathol; 1988; 33(1):55-8. PubMed ID: 3384067 [TBL] [Abstract][Full Text] [Related]